In vivo efficacy studies of clofazimine against cdad in hamster model
Ended Project Grant Awarded Last action
- Award ID
- R43AI122531
- Recipient
-
Kamtek Inc. UEI FHVVCKPSNQZ6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $290,545
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Montgomery Village, MD 20879, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$8 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $50,000 | |
| Original award | $240,553 |
Quick answers
Who received award R43AI122531?
R43AI122531 was awarded to Kamtek Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 14, 2016.
How much is award R43AI122531 worth?
$290,545 has been obligated on R43AI122531.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award